This question is the focus of this year's autumn seminar, organized by VESPA and VIPS. The different approaches are illustrated using the example of the active ingredient rivaroxaban. At 3:30 p.m., Konstantin Schallmoser and Yasmine Azzaoui from our Paris office will provide an in-depth insight into the topic. The event takes place at Hotel Schweizerhof Schweizerhofquai 3, Lucerne and starts at 9:15 AM.

Register here